Earnings History Data for Eli Lilly and Company (LLY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eli Lilly and Company

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	PM		LLY	Eli Lilly and Company	851,190	1.18	1.52	0.10	Eli Lilly Non-GAAP EPS of $1.18 misses by $0.29, revenue of $11.44B misses by $680M [10/30/2024 6:46 AM]	843.68	-59.90 (-6.63%)	803.06	-100.52 (-11.12%)	547.61 - 972.53	16,044,326	2,110,000	1,337,258
Earnings Snapshot: Eli Lilly falls short in Q3 results, lowers FY2024 outlook [10/30/2024 7:00 AM] Eli Lilly in charts: Mounjaro, Zepbound, and Humalog fuel Q3 sales growth [10/30/2024 7:17 AM] Eli Lilly drops, sending Novo lower after Q3 miss [10/30/2024 7:23 AM] AnaptysBio plunges as Eli Lilly drops arthritis drug from pipeline [10/30/2024 8:46 AM] Eli Lilly had a strong Q3, so why is its stock falling? [10/30/2024 1:43 PM] Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations [2024-10-30 07:18AM] Lilly: Q3 Earnings Snapshot [2024-10-30 07:03AM] Eli Lilly Stock Tumbles as Q3 Sales, Profits Fall Well Short of Estimates [2024-10-30 07:02AM] Eli Lilly Dives On Earnings Miss As Diabetes, Weight-Loss Drugs Fall Short [2024-10-30 07:00AM] Eli Lilly Stock Plummets After Earnings Miss [2024-10-30 06:57AM] Eli Lilly's weight-loss drug misses Wall Street expectations, shares tumble [2024-10-30 06:53AM] Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products [2024-10-30 06:45AM] A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years [2024-10-30 04:45AM] Is Eli Lilly Stock a Buy? [2024-10-30 04:40AM] Jim Cramer on Eli Lilly and Company (LLY): One Of Our Best Picks For The Charitable Trust [2024-10-30 02:49AM] AbbVies Deal for Alzheimers Antibody Raises Curtain for Roche News on Wednesday [Oct-29-24 05:31PM] Microsoft and Meta earnings, Q3 GDP, housing: What to Watch [Oct-29-24 05:15PM] Eli Lilly Q3 earnings misses Wall Street expectations, stock slips 10% in pre-market [Oct-29-24 05:03PM] Eli Lilly Q3 earnings expected to beat Wall Street expectations [Oct-29-24 05:03PM] Eli Lilly Reports Earnings Wednesday. Its All About Zepbound. [Oct-29-24 04:30PM] Google Parent Alphabet's Stock Pops as Cloud Revenue Soars on AI Demand [Oct-29-24 04:26PM] Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen. [Oct-29-24 04:11PM] Eli Lilly Says New Data Can Potentially Provide Path To Improved Donanemab Profile By Lower Risk Of Imaging Abnormalities In Patients With Early Alzheimer's [Oct-29-24 02:34PM] Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study [Oct-29-24 12:15PM] Is Eli Lilly And Co. (LLY) a Top Stock to Buy Before the Next Split? [Oct-29-24 09:31AM] J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohns disease [Oct-29-24 09:19AM] J&J and Lilly both boast IL-23 inhibitor efficacy in Crohns disease [Oct-29-24 09:19AM] Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong [Oct-29-24 08:46AM] 1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever [Oct-29-24 07:05AM] Eli Lilly's Latest Setback Could Portend an Unexpected Headwind for the Stock [Oct-29-24 06:30AM] Novo Nordisk Shares Seen Outpacing Lillys After Summer Stumble [Oct-29-24 05:07AM]
08-08-2024	PM		LLY	Eli Lilly and Company	753,840	3.92	2.64	2.11	Eli Lilly Non-GAAP EPS of $3.92 beats by $1.16, revenue of $11.3B beats by $1.33B [8/8/2024 6:46 AM]	842.91	70.77 (9.17%)	872.00	99.86 (12.93%)	502.71 - 966.10	6,922,254	3,900,000	1,056,912
Eli Lilly jumps after guidance raise on weight loss momentum [8/8/2024 7:22 AM] Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance power Q2 performance [8/8/2024 7:45 AM] Biggest stock movers today: UAA, WBD, MNST, and more [8/8/2024 10:26 AM] Volume Leaders: MCK, UAA, HOOD, LLY, and more [8/8/2024 11:52 AM] Lilly Alzheimer's asset targeting tau protein fails in phase 2 [8/8/2024 2:02 PM]
30-04-2024	PM		LLY	Eli Lilly and Company	688,750	2.58	2.53	1.62	Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M [4/30/2024 6:47 AM]	781.69	44.49 (6.03%)	778.52	41.32 (5.60%)	392.26 - 800.78	5,978,381	2,470,000	409,601
Eli Lilly raises guidance on weight loss momentum [4/30/2024 7:31 AM] Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance drive revenue growth in Q1; Trulicity declines 26% [4/30/2024 7:03 AM] Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M [4/30/2024 6:47 AM] Eli Lilly Q1 Earnings Preview: Weight loss therapies to drive quarterly growth [4/29/2024 1:13 PM]
06-02-2024	PM		LLY	Eli Lilly and Company	633,800	2.49	2.46	2.09	Eli Lilly beats top-line and bottom-line estimates; initiates FY24 outlook [2/6/2024 6:47 AM]	703.86	-2.34 (-0.33%)	743.19	36.99 (5.24%)	309.20 - 742.00	7,031,985	3,220,000	535,107
Eli Lilly beats in Q4 as obesity drug sales blow past estimates [2/6/2024 7:25 AM] Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth, while Humalog and Trulicity decline [2/6/2024 7:28 AM] 6 stocks to watch on Tuesday: Spotify, Eli Lilly, Chipotle, DocuSign and more [2/6/2024 9:15 AM] Biggest stock movers today: DocuSign, BP, Palantir Technologies, and more [2/6/2024 9:55 AM] Lilly reportedly worried about impact of Catalent/Novo deal [2/6/2024 1:23 PM]
02-11-2023	PM		LLY	Eli Lilly and Company	525,840	0.10	-0.11	1.98	Eli Lilly Non-GAAP EPS of $0.10 misses by $0.77, revenue of $9.49B beats by $500M [11/2/2023 6:34 AM]	580.29	25.83 (4.66%)	580.29	0.0 (0.00%)	309.20 - 629.97	4,768,146	2,930,000	47,639
Eli Lilly Q3 earnings on deck with GLP-1 drugs in focus [11/1/2023 12:29 PM] Eli Lilly declares $1.13 dividend [11/1/2023 7:04 AM] Eli Lilly Non-GAAP EPS of $0.10 misses by $0.77, revenue of $9.49B beats by $500M [11/2/2023 6:34 AM] Eli Lilly posts Q3 beat on diabetes drugs; pushes back Alzheimer’s prospects [11/2/2023 7:19 AM] Eli Lilly in charts: Verzenio sales surge 68.4% Y/Y, while Trulicity sales decline 10% in Q3 [11/2/2023 7:53 AM]
08-08-2023	PM		LLY	Eli Lilly and Company	426,690	2.11	1.98	1.25	Eli Lilly, up 24% YTD, looks to Q2 results beats [8/7/2023 3:08 PM]	521.10	67.02 (14.76%)	504.97	50.89 (11.21%)	296.32 - 538.00	13,442,995	2,000,000	705,887
Eli Lilly, up 24% YTD, looks to Q2 results beats [8/7/2023 3:08 PM] Eli Lilly beats Q2 top and bottom line estimates; raises FY23 EPS outlook [8/8/2023 6:47 AM] Eli Lilly Q2 beat driven by Mounjaro and growth products [8/8/2023 7:28 AM] Lilly reaches all-time high on Q2 results, 2023 guidance boost [8/8/2023 10:26 AM] Biggest stock movers today: Medical Properties Trust, Novavax, Eli Lilly, Tilray Brands, and more [8/8/2023 10:24 AM]
27-04-2023	PM	6:25 AM ET (Apr 27)	LLY	Eli Lilly and Company	366,500	1.62	1.73	2.62	Eli Lilly Non-GAAP EPS of $1.62 misses by $0.11, revenue of $6.96B beats by $90M [4/27/2023 6:48 AM]	390.77	14.50 (3.85%)	392.60	16.33 (4.34%)	280.59 - 398.53	4,261,377	2,560,000	140,648
Lilly obesity therapy shows ~16% weight loss in Phase 3 trial [4/27/2023 6:55 AM] Eli Lilly posts Q1 contraction amid hit to COVID sales [4/27/2023 9:24 AM] Zura to license autoimmune disease drug from Lilly; plans $80M private offering [4/27/2023 11:12 AM] Eli Lilly to use priority review voucher for Mounjaro weight loss indication [4/27/2023 11:46 AM] Hot Stocks: TDOC, LLY, ROKU and CMCSA rises on earnings; DBX falls on layoffs; LUV, CAT and BMY slides [4/27/2023 1:01 PM]
02-02-2023	PM	6:25 AM ET (Feb 2)	LLY	Eli Lilly and Company	323,540	2.09	1.83	2.49	Eli Lilly Non-GAAP EPS of $2.09 beats by $0.24, revenue of $7.3B misses by $90M [2/2/2023 6:49 AM]	330.50	-12.07 (-3.52%)	333.50	-9.07 (-2.65%)	231.87 - 384.44	12,311,933	2,920,000	96,184
Eli Lilly to report Q4 earnings amid forex headwinds, loss of COVID-19 antibody revenue [2/1/2023 10:44 AM] Eli Lilly Non-GAAP EPS of $2.09 beats by $0.24, revenue of $7.3B misses by $90M [2/2/2023 6:49 AM] Eli Lilly slips as falling demand for COVID therapy hurts topline [2/2/2023 7:41 AM] Lilly's quarterly results impacted by less than expected growth in diabetes drug Mounjaro [2/2/2023 1:49 PM] U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates [2/2/2023 2:11 PM]
01-11-2022	PM	6:25 AM ET (Nov 1)	LLY	Eli Lilly and Company	341,970	1.98	1.97	1.94	Eli Lilly Non-GAAP EPS of $2.04 beats by $0.11, revenue of $6.94B beats by $30M, cuts FY22 outlook [11/1/2022 6:27 AM]	352.99	-9.10 (-2.51%)	345.73	-16.36 (-4.52%)	231.87 - 363.92	6,078,277	2,740,000	158,719
What to expect from Eli Lilly Q3 2022 Earnings [10/31/2022 10:38 AM] Eli Lilly Non-GAAP EPS of $2.04 beats by $0.11, revenue of $6.94B beats by $30M, cuts FY22 outlook [11/1/2022 6:27 AM] Lilly falls as FY22 outlook cut on forex impact, Trulicity drives Q3 sales [11/1/2022 7:19 AM]
04-08-2022	PM	6:25 AM ET (Aug 4)	LLY	Eli Lilly and Company	312,360	1.25	1.80	1.87	Eli Lilly Non-GAAP EPS of $1.71 in-line, revenue of $6.48B misses by $370M, cuts FY22 EPS guidance [8/4/2022 6:26 AM]	305.66	-8.17 (-2.60%)	310.00	-3.83 (-1.22%)	220.20 - 335.33	3,978,151	2,550,000	104,242
What to expect from Eli Lilly Q2 2022 earnings? [8/3/2022 1:43 PM] Eli Lilly Non-GAAP EPS of $1.71 in-line, revenue of $6.48B misses by $370M, cuts FY22 EPS guidance [8/4/2022 6:26 AM] Eli Lilly slips as quarterly revenue declines for the first time in two years [8/4/2022 7:10 AM] Hot Stocks: MELI & XELA jump over 10%, LLY falls on revenue miss, FTNT slides on revised estimates [8/4/2022 8:20 AM] Eli Lilly ordered to pay $183M in whistleblower Medicaid fraud case - Bloomberg [8/4/2022 1:18 PM]
28-04-2022	PM	6:25 AM ET (Apr 28)	LLY	Eli Lilly and Company	269,350	2.62	2.32	1.87	Eli Lilly Non-GAAP EPS of $2.62 beats by $0.32, revenue of $7.81B beats by $520M [4/28/2022 6:26 AM]	297.32	12.24 (4.29%)	295.00	9.91 (3.48%)	178.58 - 314.00	5,142,884	2,310,000	188,228
Eli Lilly Q1 result to focus on COVID-19 therapies sales, comments on Alzheimer's drug [4/27/2022 1:22 PM] Eli Lilly Non-GAAP EPS of $2.62 beats by $0.32, revenue of $7.81B beats by $520M [4/28/2022 6:26 AM] Lilly Q1 revenue soars on COVID antibodies, Trulicity; raises FY22 revenue outlook, cuts EPS guidance [4/28/2022 7:55 AM] Lilly's tirzepatide shows weight loss benefit in adults without diabetes [4/28/2022 9:28 AM] Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More [Apr-27-22 02:03PM] Best Healthcare Stocks To Buy Now [Apr-27-22 11:53AM] Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022 [Apr-28-22 06:25AM] Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1 [Apr-28-22 06:15AM] Eli Lilly Stock Leaps As Trulicity Sales Drive Q1 Earnings Beat, 2022 Outlook Boost [Apr-28-22 06:34AM] Drugmaker Eli Lilly profit jumps on robust demand for diabetes drug [Apr-28-22 06:36AM] Eli Lilly Beats Estimates and the Stock Rises on Revenue Guidance Boost [Apr-28-22 06:34AM] Eli Lilly stock rallies after earnings beat expectations, as COVID-19 antibodies revenue jumps 81% [Apr-28-22 06:45AM] Eli Lilly Stock Leaps As Trulicity Sales Drive Q1 Earnings Beat, Obesity Drug Trial Data [Apr-28-22 07:23AM] Eli Lilly Beats Estimates and the Stock Jumps on Revenue Guidance Boost [Apr-28-22 07:26AM] I'm Prescribing a New Approach Toward Eli Lilly as It Loses Upward Momentum [Apr-28-22 07:55AM] Eli Lilly Rallies On First-Quarter Beat And As Obesity Drug Cuts 20% Body Weight [Apr-28-22 08:36AM] Eli Lilly shares gain after results beat estimates, obesity drug data [Apr-28-22 06:36AM] Lilly says its experimental weight-loss treatment led to 20% weight loss in clinical-trial participants [Apr-28-22 08:54AM] Eli Lilly (LLY) Q1 Earnings and Revenues Top Estimates [Apr-28-22 07:35AM] Eli Lilly Extends Its Breakout On First-Quarter Beat, Bullish News In Obesity [Apr-28-22 09:49AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GPD Falls In Q1 [Apr-28-22 10:36AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GDP Falls In Q1 [Apr-28-22 10:36AM] Eli Lilly obesity drug data shines, shares rise [Apr-28-22 06:36AM] Robinhood, Apple, Amazon set to report earnings after the bell [Apr-28-22 12:08PM] Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises [Apr-28-22 11:12AM] GDP Declined in First Quarter [Apr-28-22 11:06AM] Amgen's (AMGN) Q1 Earnings Top, Stock Down on IRS Tax Dispute [Apr-28-22 10:44AM] Q1 GDP Negative; Q1 Earnings Beats from CAT, LLY, MCD [Apr-28-22 10:37AM] Eli Lilly Achieves 80% Jump In COVID-19 Therapy Sales, Revises FY22 Guidance [Apr-28-22 11:45AM] Eli Lilly says obesity drugs results compare to weight-loss surgery [Apr-28-22 02:38PM] Eli Lilly and Company (LLY) Q1 2022 Earnings Call Transcript [Apr-28-22 03:30PM] Dow Jones Futures Fall After Facebook-Led Market Rally; Apple Earnings Top, Amazon Tumbles [Apr-28-22 07:38PM]
03-02-2022	PM	6:25 AM ET (Feb 3)	LLY	Eli Lilly and Company	234,740	2.49	2.51	2.75	Eli Lilly Non-GAAP EPS of $2.49 misses by $0.02, revenue of $8B beats by $110M [2/3/2022 6:27 AM]	244.41	-6.42 (-2.56%)	248.62	-2.21 (-0.88%)	178.58 - 283.90	2,959,820	2,810,000	6,640
What's in store for Eli Lilly's Q4 earnings? [2/2/2022 7:11 AM] Eli Lilly Non-GAAP EPS of $2.49 misses by $0.02, revenue of $8B beats by $110M [2/3/2022 6:27 AM] Eli Lilly tops Q4 revenue estimates as sales of COVID-19 antibodies exceed $1B [2/3/2022 7:27 AM] Eli Lilly pushes back regulatory submissions for Alzheimer’s drug [2/3/2022 1:10 PM] Sustainable Insight Capital Management, LLC Buys Eli Lilly and Co, NXP Semiconductors NV, ... [Feb-02-22 05:38PM] Provident Wealth Management, LLC Buys iShares Core MSCI Emerging Markets ETF, First Trust ... [Feb-02-22 01:38PM] Novo Nordisk's (NVO) Q4 Earnings and Sales Beat Estimates [Feb-02-22 12:48PM] Drug/Biotech Stocks Earnings on Feb 3: BIIB, LLY & MRK [Feb-02-22 12:31PM] Was The Smart Money Right About Eli Lilly and Company (LLY)? [Feb-02-22 11:10AM] Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing [Feb-02-22 10:27AM] UNICEF and Lilly Collaborate to Help Improve Health Outcomes for 10 Million Children and Adolescents [Feb-02-22 10:00AM] Foster Group, Inc. Buys Vanguard Total Bond Market ETF, Vanguard Short-Term Inflation-Protected ... [Feb-02-22 09:38AM] REFILE-UPDATE 1-Novo rejects U.S. insulin price hikes report, has 'nothing to hide' [Feb-02-22 09:35AM] REFILE-Novo Nordisk rejects U.S. report on aggressive insulin price hikes [Feb-02-22 07:39AM] Eli Lilly stock gains after earnings rise above expectations, as COVID-19 antibodies revenue top $1 billion [Feb-03-22 06:38AM] Eli Lillys Earnings Top Forecasts. The Stock Dips. [Feb-03-22 06:45AM] Eli Lilly Posts an Earnings Beat and Maintains Its 2022 Forecast [Feb-03-22 06:59AM] Earnings Live Blog: Merck, Eli Lilly, Honeywell and Estee Lauder Post Quarterly Updates [Feb-03-22 02:37AM] Earnings Live Blog: Merck, Eli Lilly, Honeywell, Estee Lauder And Biogen Post Quarterly Updates [Feb-03-22 02:47AM] Eli Lilly results beat on demand for Trulicity, COVID antibody therapies [Feb-03-22 06:35AM] UPDATE 2-Eli Lilly results beat on demand for Trulicity, COVID antibody therapies [Feb-03-22 06:48AM] Dow Jones Futures Fall As Facebook Crashes On Earnings; Amazon Earnings On Deck [Feb-03-22 08:11AM] Dow Jones Futures Fall, Tech Futures Dive As Facebook Crashes On Earnings; Amazon Earnings On Deck [Feb-03-22 08:51AM] Lilly's Covid Antibodies Drove A Big Beat, But Omicron Will Limit Sales [Feb-03-22 09:11AM] Dow Jones Falls, Tech Stocks Dive As Facebook Crashes On Earnings; Amazon Earnings On Deck [Feb-03-22 09:37AM] Greenhouse Wealth Management, LLC Buys Eli Lilly and Co, Johnson & Johnson, Oracle Corp, ... [Feb-03-22 09:38AM] Eli Lilly results beat on diabetes drug, COVID antibody therapies [Feb-03-22 06:35AM] UPDATE 3-Eli Lilly results beat on diabetes drug, COVID antibody therapies [Feb-03-22 06:48AM] Social media stocks fall on Meta rerating, Qualcomm shares down, pharmaceutical stocks decline [Feb-03-22 10:02AM] Eli Lilly Falls on Pricing Pressure in Key Markets [Feb-03-22 03:02AM] Meta Platforms, Spotify, Biogen Fall Premarket; T-Mobile Rises [Feb-03-22 03:18AM] Facebook Shares Hammered, Driving Markets Lower [Feb-03-22 10:41AM] Eli Lilly Q4 Earnings Beat Estimates On Higher Demand For Trulicity, COVID-19 Therapies; Reaffirms FY22 Guidance [Feb-03-22 09:11AM] Hershey Forecasts FY22 Sales, Profit Above Estimates On Higher Prices [Feb-03-22 09:15AM] UPDATE 4-Eli Lilly pushes back timeline for Alzheimer's drug application [Feb-03-22 06:48AM] Cigna Shares Fall As FY22 Guidance Falls Short Of Consensus; Q4 Profit Of $1.1B [Feb-03-22 09:37AM] Merck (MRK) Q4 Earnings & Sales Beat, COVID Drug Adds $952M [Feb-03-22 11:46AM] Northstar Asset Management Llc Buys PayPal Holdings Inc, Vanguard ESG U.S. ... [Feb-03-22 01:38PM] Merrion Investment Management Co, LLC Buys iShares TIPS Bond ETF, ViacomCBS Inc, Canadian ... [Feb-03-22 01:38PM] Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales [Feb-03-22 01:38PM] Merck, Eli Lilly Covid-19 Treatments Power Quarterly Sales Gains [Feb-03-22 04:25PM]
26-10-2021	PM	6:25 AM ET (Oct 26)	LLY	Eli Lilly and Company	230,700	1.94	1.98	1.54	Eli Lilly EPS misses by $0.02, beats on revenue, boost guidance [10/26/2021 6:28 AM]	248.46	3.41 (1.39%)	244.50	-0.55 (-0.22%)	129.21 - 275.87	4,018,029	2,030,000	81,101
Eli Lilly Q3 2021 Earnings Preview [10/25/2021 2:20 PM] Eli Lilly EPS misses by $0.02, beats on revenue, boost guidance [10/26/2021 6:28 AM] Eli Lilly shares rise after Q3 topline beat, FY forecast raise [10/26/2021 6:55 AM] Eli Lilly begins rolling submission of Alzheimer's candidate donanemab [10/26/2021 11:07 AM] Cramer: Stop freaking out about inflation here's how to profit from soaring costs [Oct-25-21 06:10PM] Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential [Oct-26-21 06:25AM] Eli Lilly Misses Profit Estimates but Boosts Guidance. The Stock Is Rising. [Oct-26-21 06:42AM] UPDATE 1-Lilly raises 2021 outlook on higher COVID-19 drugs sales [Oct-26-21 06:50AM] Eli Lilly & Co. net income falls 8%, but adjusted profit rises [Oct-26-21 06:50AM] Lilly raises 2021 outlook on higher COVID-19 drugs sales [Oct-26-21 06:31AM] Eli Lilly Stock Jumps After 2021 Outlook Boost Offsets Q3 Earnings Miss [Oct-26-21 02:53AM] Eli Lilly Earnings Missed Estimates. Heres Why the Stock Is Rising. [Oct-26-21 07:19AM] UPDATE 2-Lilly raises 2021 outlook on higher COVID-19 drugs sales [Oct-26-21 06:50AM] Lilly plans to run clinical trial comparing its Alzheimer's drug candidate to Biogen's Aduhelm [Oct-26-21 08:02AM] Eli Lilly Stock Gains After 2021 Outlook Boost Offsets Q3 Earnings Miss [Oct-26-21 04:22AM] Facebook, Uber, UPS and General Electric Rise Premarket [Oct-26-21 03:53AM] Eli Lilly Posts Mixed Third Quarter, But Raises 2021 Sales Guidance [Oct-26-21 08:55AM] UPDATE 3-Lilly kicks off application for Alzheimer's drug U.S. approval, ups outlook [Oct-26-21 06:50AM] Lilly kicks off application for Alzheimer's drug U.S. approval, ups outlook [Oct-26-21 06:31AM] Eli Lilly (LLY) Misses Q3 Earnings Estimates [Oct-26-21 07:45AM] Eli Lilly Stock Slides On Q3 Earnings Miss, COVID Therapy Sales Outlook [Oct-26-21 05:44AM] Hasbro warns supply chain bottlenecks, Sherwin-Williams cuts guidance on inflation fears, Lilly raises 2021 outlook [Oct-26-21 10:38AM] The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children [Oct-26-21 08:30AM] The Eli Lilly-Biogen Clash In Alzheimer's Begins How Will It Play Out? [Oct-26-21 11:48AM] Eli Lilly Is Asking the FDA to Approve Its Alzheimers Therapy [Oct-26-21 11:47AM] Eli Lilly (LLY) Q3 Earnings Miss, COVID Drugs Drive Sales [Oct-26-21 10:36AM] Home Prices Stay "Lofty;" UPS Beats, Lilly Mixed [Oct-26-21 10:19AM] UPDATE 4-Lilly kicks off application for Alzheimer's drug U.S. approval [Oct-26-21 06:50AM] Eli Lilly Q3 Earnings Beat Estimates, Boosts FY21 Guidance On Higher COVID-19 Therapy Sales [Oct-26-21 08:48AM] Eli Lilly Stock Gains After2021 Outlook Lift Following Q3 Earnings [Oct-26-21 10:02AM] Eli Lilly Earnings Disappointed. Why the Stock Is Rising. [Oct-26-21 02:09PM] Eli Lilly and Company (LLY) Q3 2021 Earnings Call Transcript [Oct-26-21 04:30PM]
03-08-2021	PM	6:25 AM ET (Aug 3)	LLY	Eli Lilly and Company	233,520	1.87	1.89	1.89	Eli Lilly EPS misses by $0.02, beats on revenue [8/3/2021 6:31 AM]	255.99	9.39 (3.81%)	240.00	-6.60 (-2.68%)	129.21 - 259.37	4,932,383	2,040,000	50,317
Eli Lilly Q2 2021 Earnings Preview [8/2/2021 3:14 PM] Eli Lilly EPS misses by $0.02, beats on revenue [8/3/2021 6:31 AM] Eli Lilly posts Q2 topline beat on Trulicity, Humalog strength; updates FY forecast [8/3/2021 6:53 AM] Lilly, Incyte's baricitinib reduces deaths among COVID-19 patients on mechanical ventilation [8/3/2021 6:55 AM] Lilly says Alzheimer's therapy donanemab could be favored over Biogen's Aduhelm [8/3/2021 1:10 PM] Eli Lilly (LLY) Option Traders Prepped for Earnings Beat [Aug-02-21 06:18PM] Lilly, Marriott, Lyft Earnings: 3 Things to Watch [Aug-02-21 11:53AM] Drug/Biotech Stock Q2 Earnings on Aug 3: LLY, AMGN & More [Aug-02-21 09:36AM] Eli Lilly Near Record High Ahead of Earnings; Target Price $300 in Best Case [Aug-03-21 12:38AM] Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation [Aug-03-21 06:00AM] Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance [Aug-03-21 06:25AM] UPDATE 1-Lilly's COVID-19 drug reduces death risk in patients on mechanical ventilation [Aug-03-21 06:31AM] Eli Lilly Earnings Fall Short, Sales Top; LLY Stock Falls Slightly [Aug-03-21 06:41AM] UPDATE 1-Drugmaker Eli Lilly profit slips on weak demand for COVID-19 therapies [Aug-03-21 06:38AM] Eli Lilly's stock falls after profit comes up short of expectations, while revenue beat [Aug-03-21 06:44AM] Eli Lilly Stock Slides on Earnings Miss, Outlook Change; Trulicity Sales Impress [Aug-03-21 02:42AM] Drugmaker Eli Lilly profit hit by weak demand for pandemic drugs [Aug-03-21 06:29AM] Mask Mandates, Chinese Gaming Shock, API Inventories - What's Moving Markets [Aug-03-21 02:36AM] PepsiCo, Under Armour Rise Premarket; Eli Lilly, Clorox Fall [Aug-03-21 03:59AM] 10 Stocks to Buy According to Neil Shahrestanis Ikarian Capital [Aug-03-21 09:01AM] Eli Lilly (LLY) Lags Q2 Earnings Estimates [Aug-03-21 07:35AM] Eli Lilly Stock Hits Record High On Trulicity Sales, Alzheimer's Drug Plans [Aug-03-21 05:50AM] Eli Lilly Stock Is Soaring. Sales Bounced Back. [Aug-03-21 10:37AM] Eli Lilly Earnings Missed Expectations. Why the Stock Is Soaring. [Aug-03-21 11:01AM] Eli Lilly Stock Hits A Record High Despite Mixed Quarter As Alzheimer's Enthusiasm Grows [Aug-03-21 11:15AM] Eli Lilly bets on Alzheimer's disease drug data as it chases Biogen [Aug-03-21 06:29AM] UPDATE 4-Eli Lilly bets on Alzheimer's disease drug data as it chases Biogen [Aug-03-21 06:38AM] S&P 500 Climbs as Energy, Industrials Shine [Aug-03-21 09:42AM] Eli Lilly (LLY) Q2 Earnings Miss, Sales Beat, Stock Down [Aug-03-21 12:21PM] Eli Lilly and Company (LLY) Q2 2021 Earnings Call Transcript [Aug-03-21 05:01PM]
27-04-2021	PM	6:20 AM ET (Apr 27)	LLY	Eli Lilly and Company	180,980	1.87	2.12	1.75	Eli Lilly EPS misses by $0.23, misses on revenue [4/27/2021 6:26 AM]	182.38	-4.83 (-2.58%)	183.71	-3.51 (-1.87%)	129.21 - 218.00	5,891,515	2,730,000	243,041
Eli Lilly Q1 2021 Earnings Preview [4/26/2021 12:36 PM] Eli Lilly EPS misses by $0.23, misses on revenue [4/27/2021 6:26 AM] Lilly slips 4% as Q4 trails estimates; Guidance lags consensus; COVID-19 antibody revenues of $810M [4/27/2021 7:17 AM] Eli Lilly Rated Top in Innovation, Bristol-Myers Leader in Invention [Apr-26-21 07:29PM] Eli Lilly and Company's (NYSE:LLY) CEO Will Probably Have Their Compensation Approved By Shareholders [Apr-26-21 02:08AM] Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance [Apr-27-21 06:25AM] Eli Lilly misses profit estimates on lower COVID-19 drug demand [Apr-27-21 06:41AM] Eli Lilly shares slide 5% premarket as earnings fall short of estimates and guidance lags consensus [Apr-27-21 06:40AM] Eli Lilly Misses Earnings Forecast, Lowers Full-Year Profit Guidance [Apr-27-21 02:40AM] UPDATE 1-Eli Lilly misses profit estimates on lower COVID-19 drug demand [Apr-27-21 06:46AM] UPDATE 2-Eli Lilly profit misses estimates on lower COVID-19 drug demand [Apr-27-21 06:46AM] Eli Lilly profit misses estimates on lower COVID-19 drug demand [Apr-27-21 06:41AM] Eli Lilly Earnings Miss Views, Drug Giant Guides Lower [Apr-27-21 07:53AM] UPDATE 3-Eli Lilly profit misses as vaccines sap U.S. demand for COVID-19 drugs [Apr-27-21 06:46AM] Eli Lilly profit misses as vaccines sap U.S. demand for COVID-19 drugs [Apr-27-21 06:41AM] Eli Lilly Cuts Earnings Forecast as Profits Fall Short [Apr-27-21 08:11AM] Eli Lilly (LLY) Q1 Earnings and Revenues Miss Estimates [Apr-27-21 07:45AM] Eli Lilly Rated Tops in Innovation, Bristol-Myers Leader in Invention [Apr-26-21 07:29PM] Eli Lilly (LLY) Q1 Earnings Miss, COVID-19 Drug Demand Low [Apr-27-21 09:03AM] Eli Lilly Stock Crumbles As Covid Antibodies Hammer Sales, 2021 Outlook [Apr-27-21 10:14AM] Crocs posts blowout earnings, Hasbro tops Q1 estimates [Apr-27-21 10:12AM] Earnings Season in Full Swing [Apr-27-21 09:51AM] Markets, GE Q1 Mixed; UPS Beats Big [Apr-27-21 10:34AM] UPDATE 4-Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for COVID-19 drugs [Apr-27-21 06:46AM] Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for COVID-19 drugs [Apr-27-21 06:41AM] Why Investors Didn't Like Lilly's Q1 Results [Apr-27-21 11:32AM] Eli Lilly Shares Drop After Missing Q1 Earnings On Lower COVID-19 Drug Demand; 2021 Guidance Lagging Consensus [Apr-27-21 08:27AM] Lillys COVID-19 antibody drugs are a top seller this quarter, but investors arent that excited [Apr-27-21 02:34PM] Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript [Apr-27-21 04:00PM] Eli Lilly Abandons IL-23 Psoriasis Program, Instead Will Focus On Ulcerative Colitis, Crohn's Disease Indications [Apr-27-21 02:34PM]
29-01-2021	PM	6:30 AM ET (Jan 29)	LLY	Eli Lilly and Company	203,480	2.75	2.35	1.73	Eli Lilly EPS beats by $0.36, beats on revenue [1/29/2021 6:21 AM]	209.08	1.15 (-0.50%)	217.50	7.38 (3.51%)	117.06 - 218.00	6,774,827	6,431,326	94,695
Eli Lilly EPS beats by $0.36, beats on revenue [1/29/2021 6:21 AM] Eli Lilly Q4 2020 Earnings Preview [1/28/2021 1:15 PM] Eli Lilly, Asahi Kasei Pharma inks licensing pact for chronic pain drug candidate [1/28/2021 7:16 AM] Lilly tops Q4 forecast, Trulicity sales up 24%, GAAP EPS guidance lowered [1/29/2021 6:58 AM] Biogen’s FDA review extension: ‘a positive for Lilly’s Alzheimer perception' – MS [1/29/2021 2:19 PM] Economic Prints, Q4 Reports Up for Lilly, CAT; J&J Posts Phase-3 Data [Jan-29-21 10:29AM] Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates [Jan-29-21 10:22AM] REFILE-US STOCKS-Wall St set to open lower after J&J vaccine data [Jan-29-21 09:11AM] Can Eli Lilly and Regeneron Antibody Treatments Beat New COVID Strains? [Jan-29-21 08:32AM] Recap: Eli Lilly Q4 Earnings [Jan-29-21 07:03AM] Eli Lilly beats profit and sales forecasts, to deliver 500,000 more COVID-19 treatment doses by end of March [Jan-29-21 06:37AM] Eli Lilly profit beats estimates on demand for cancer, diabetes drugs [Jan-29-21 06:31AM] Lilly Reports Strong Fourth-Quarter and Full-Year 2020 Financial Results [Jan-29-21 06:20AM] Johnson & Johnson, Lilly, Caterpillar, Chevron - Friday's Premarket Movers [Jan-29-21 03:56AM] Eli Lilly Tops Q4 Earnings Forecast, Sees COVID Therapies Sales Boost in 2021 [Jan-29-21 01:38AM]
27-10-2020	PM	6:25 AM ET (Oct 27)	LLY	Eli Lilly and Company	136,180	1.54	1.76	1.48	Eli Lilly EPS misses by $0.17, misses on revenue [10/27/2020 6:32 AM]	132.10	-8.70 (-6.77%)	134.30	-7.40 (-5.22%)	110.51 - 170.75	10,389,748	3,114,390	313,210

30-07-2020	PM	6:25 AM ET (Jul 30)	LLY	Eli Lilly and Company	155,570	1.89	1.58	1.50	Eli Lilly EPS beats by $0.29, misses on revenue [7/30/2020 6:27 AM]	152.32	-9.43 (-5.83%)	157.90	-3.85 (-2.38%)	101.36 - 170.75	3,674,673	2,350,656	41,337